BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jin X, Dai L, Ma Y, Wang J, Liu Z. Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer. Cancer Cell Int 2020;20:273. [PMID: 32587480 DOI: 10.1186/s12935-020-01370-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu T, Li G, Wang C, Gong G, Wang L, Li C, Chen Y, Wang X. MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/HK2/PKM2 axis. RNA Biol 2021;:1-18. [PMID: 34110962 DOI: 10.1080/15476286.2021.1930755] [Reference Citation Analysis]
2 Mani S, Swargiary G, Ralph SJ. Targeting the redox imbalance in mitochondria: A novel mode for cancer therapy. Mitochondrion 2021;62:50-73. [PMID: 34758363 DOI: 10.1016/j.mito.2021.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Zhang Y, Liu Q, Yang S, Liao Q. Knockdown of LRRN1 inhibits malignant phenotypes through the regulation of HIF-1α/Notch pathway in pancreatic ductal adenocarcinoma. Mol Ther Oncolytics 2021;23:51-64. [PMID: 34632050 DOI: 10.1016/j.omto.2021.08.012] [Reference Citation Analysis]
4 Soetens E, Ballegeer M, Saelens X. An Inside Job: Applications of Intracellular Single Domain Antibodies. Biomolecules 2020;10:E1663. [PMID: 33322697 DOI: 10.3390/biom10121663] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Geismann C, Arlt A. Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer. Cells 2020;9:E2353. [PMID: 33113836 DOI: 10.3390/cells9112353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sparks K, Couturier CS, Buskirk J, Flores A, Hoeferle A, Hoffman J, Stecyk JAW. Gene expression of hypoxia-inducible factor (HIF), HIF regulators, and putative HIF targets in ventricle and telencephalon of Trachemys scripta acclimated to 21 °C or 5 °C and exposed to normoxia, anoxia or reoxygenation. Comp Biochem Physiol A Mol Integr Physiol 2022;267:111167. [PMID: 35182763 DOI: 10.1016/j.cbpa.2022.111167] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gómez-Valenzuela F, Escobar E, Pérez-Tomás R, Montecinos VP. The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition. Front Oncol 2021;11:686792. [PMID: 34178680 DOI: 10.3389/fonc.2021.686792] [Reference Citation Analysis]
8 Huang X, Liu F, Jiang Z, Guan H, Jia Q. CREB1 Suppresses Transcription of microRNA-186 to Promote Growth, Invasion and Epithelial-Mesenchymal Transition of Gastric Cancer Cells Through the KRT8/HIF-1α Axis. Cancer Manag Res 2020;12:9097-111. [PMID: 33061604 DOI: 10.2147/CMAR.S265187] [Reference Citation Analysis]
9 Wnorowski A, Dudzik D, Bernier M, Wójcik J, Keijzers G, Diaz-ruiz A, Mazur K, Zhang Y, Han H, Scheibye-knudsen M, Jozwiak K, Barbas C, Wainer IW. Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-07600-x] [Reference Citation Analysis]
10 Hamada S, Matsumoto R, Masamune A. HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer. Cancers 2022;14:411. [DOI: 10.3390/cancers14020411] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Zhu PF, Wang MX, Chen ZL, Yang L. Targeting the Tumor Microenvironment: A Literature Review of the Novel Anti-Tumor Mechanism of Statins. Front Oncol 2021;11:761107. [PMID: 34858839 DOI: 10.3389/fonc.2021.761107] [Reference Citation Analysis]
12 Gillson J, Abd El-aziz YS, Leck LYW, Jansson PJ, Pavlakis N, Samra JS, Mittal A, Sahni S. Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target. Cancers 2022;14:3528. [DOI: 10.3390/cancers14143528] [Reference Citation Analysis]
13 Song X, He J, Shi B, Han Y. Hypoxic Microenvironment-Induced Reduction in PTEN-L Secretion Promotes Non-Small Cell Lung Cancer Metastasis through PI3K/AKT Pathway. Evid Based Complement Alternat Med 2022;2022:6683104. [PMID: 35280516 DOI: 10.1155/2022/6683104] [Reference Citation Analysis]
14 Das S, Shukla N, Singh SS, Kushwaha S, Shrivastava R. Mechanism of interaction between autophagy and apoptosis in cancer. Apoptosis 2021;26:512-33. [PMID: 34510317 DOI: 10.1007/s10495-021-01687-9] [Reference Citation Analysis]
15 Malekan M, Ebrahimzadeh MA, Sheida F. The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma. Biomed Pharmacother 2021;141:111873. [PMID: 34225012 DOI: 10.1016/j.biopha.2021.111873] [Reference Citation Analysis]
16 Gao Y, Zhang E, Fei X, Kong L, Liu P, Tan X. Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction Model. Front Cell Dev Biol 2021;9:691161. [PMID: 34447748 DOI: 10.3389/fcell.2021.691161] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Jin Y, Zhang Z, Yu Q, Zeng Z, Song H, Huang X, Kong Q, Hu H, Xia Y. Positive Reciprocal Feedback of lncRNA ZEB1-AS1 and HIF-1α Contributes to Hypoxia-Promoted Tumorigenesis and Metastasis of Pancreatic Cancer. Front Oncol 2021;11:761979. [PMID: 34881179 DOI: 10.3389/fonc.2021.761979] [Reference Citation Analysis]
18 Gonçalves DA, Jasiulionis MG, Melo FHM. The Role of the BH4 Cofactor in Nitric Oxide Synthase Activity and Cancer Progression: Two Sides of the Same Coin. Int J Mol Sci 2021;22:9546. [PMID: 34502450 DOI: 10.3390/ijms22179546] [Reference Citation Analysis]
19 Amrutkar M, Gladhaug IP. Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer. Cancers (Basel) 2021;13:601. [PMID: 33546284 DOI: 10.3390/cancers13040601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wu Y, Lu M, Lin T, Chu P, Chang C. Synthesis and Evaluation of Biarylquinoline Derivatives as Novel HIF-1α Inhibitors. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105681] [Reference Citation Analysis]
21 Cha JE, Bae WY, Choi JS, Lee SH, Jeong JW. Angiogenic activities are increased via upregulation of HIF-1α expression in gefitinib-resistant non-small cell lung carcinoma cells. Oncol Lett 2021;22:671. [PMID: 34345296 DOI: 10.3892/ol.2021.12932] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Liu Y, Xiang D, Zhang H, Yao H, Wang Y. Hypoxia-Inducible Factor-1: A Potential Target to Treat Acute Lung Injury. Oxid Med Cell Longev 2020;2020:8871476. [PMID: 33282113 DOI: 10.1155/2020/8871476] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Hussen BM, Abdullah ST, Rasul MF, Salihi A, Ghafouri-Fard S, Hidayat HJ, Taheri M. MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets. Front Mol Biosci 2021;8:764025. [PMID: 34778378 DOI: 10.3389/fmolb.2021.764025] [Reference Citation Analysis]
24 Sexton RE, Uddin MH, Bannoura S, Khan HY, Mzannar Y, Li Y, Aboukameel A, Al-Hallak MN, Al-Share B, Mohamed A, El-Rayes B, Azmi AS. Connecting the Human Microbiome and Pancreatic Cancer. Cancer Metastasis Rev 2022. [PMID: 35366155 DOI: 10.1007/s10555-022-10022-w] [Reference Citation Analysis]
25 Rahman A, N P, N NB, Kumaraswamy HM, Rajeshwara AN, Satyanarayan ND. Synthesis and anticancer screening of some novel Pd-catalysed 3-methyl indole based analogues on Mia PaCa-2 cell line. Journal of Molecular Structure 2022;1264:133211. [DOI: 10.1016/j.molstruc.2022.133211] [Reference Citation Analysis]
26 Abe H, Okazawa M, Oyama T, Yamazaki H, Yoshimori A, Kamiya T, Tsukimoto M, Takao K, Sugita Y, Sakagami H, Abe T, Tanuma SI. A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling. Medicines (Basel) 2021;8:17. [PMID: 33805209 DOI: 10.3390/medicines8040017] [Reference Citation Analysis]
27 Alzhrani R, Alsaab HO, Vanamal K, Bhise K, Tatiparti K, Barari A, Sau S, Iyer AK. Overcoming the Tumor Microenvironmental Barriers of Pancreatic Ductal Adenocarcinomas for Achieving Better Treatment Outcomes. Adv Ther (Weinh) 2021;4:2000262. [PMID: 34212073 DOI: 10.1002/adtp.202000262] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Suwannakul N, Armartmuntree N, Thanan R, Midorikawa K, Kon T, Oikawa S, Kobayashi H, Ma N, Kawanishi S, Murata M. Targeting fructose metabolism by glucose transporter 5 regulation in human cholangiocarcinoma. Genes & Diseases 2021. [DOI: 10.1016/j.gendis.2021.09.002] [Reference Citation Analysis]
29 El-Shaqanqery HE, Mohamed RH, Sayed AA. Mitochondrial Effects on Seeds of Cancer Survival in Leukemia. Front Oncol 2021;11:745924. [PMID: 34692527 DOI: 10.3389/fonc.2021.745924] [Reference Citation Analysis]
30 Nik Mohamed Kamal NNS, Abdul Aziz FA, Tan WN, Fauzi AN, Lim V. Mechanistic Actions between Garcinia atroviridis Essential Oil and 2 Deoxy-d-glucose in Cultured PANC-1 Human Pancreatic Cancer Cells. Molecules 2021;26:3518. [PMID: 34207699 DOI: 10.3390/molecules26123518] [Reference Citation Analysis]
31 Qiu CJ, Wang XB, Zheng ZR, Yang CZ, Lin K, Zhang K, Tu M, Jiang KR, Gao WT. Development and validation of a ferroptosis-related prognostic model in pancreatic cancer. Invest New Drugs 2021. [PMID: 34195903 DOI: 10.1007/s10637-021-01114-5] [Reference Citation Analysis]
32 Tian Y, Bai F, Zhang D, Isaguliants M. HIF1α: A Novel Biomarker with Potential Prognostic and Immunotherapy in Pan-cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1-17. [DOI: 10.1155/2022/1246267] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Lai H, Kuo Y, Huang Y, Chan S, Cheng K, Wu Z. Pancreatic Cancer and Microenvironments: Implications of Anesthesia. Cancers 2022;14:2684. [DOI: 10.3390/cancers14112684] [Reference Citation Analysis]